Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

News Daily News

Signs of Cardiac Damage Even in Younger, Nonhospitalized COVID-19 Patients

Shelley Wood

July 29, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

L.A. McKeown

September 13, 2019

News Industry News

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

July 23, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Industry News

Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries

April 16, 2019

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Daily News

High-Sensitivity Troponin May Help Uncover Heart Failure Risk

Todd Neale

January 11, 2018

News Daily News

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Leah Lawrence

August 01, 2017

Advertisement

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

What’s Going to Be Hot at ACC/WCC 2023?

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

CV Care Around Noncardiac Surgery: New ESC Guidelines

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Signs of Cardiac Damage Even in Younger, Nonhospitalized COVID-19 Patients

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

High-Sensitivity Troponin May Help Uncover Heart Failure Risk

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content